Analyst consensus rating
Tonix Pharmaceuticals Holding Analyst Rating: Strong Buy
TNXP is rated Strong Buy by 5 analysts with a $42.40 target. As of 2026-08-30.
Direct answer
Tonix Pharmaceuticals Holding's consensus rating is Strong Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $42.40.
Forecast evidence checked August 30, 2026.
Get free Tonix Pharmaceuticals Holding email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $13.59
- Average price target
- $42.40
- High price target
- $65.00
- Low price target
- $22.00
- Low target gap
- +61.9%
- Target upside
- +212%
- High target gap
- +378.3%
- Target range width
- 316.4%
- Consensus rating
- Strong Buy
- Analysts
- 5
- Evidence date
- August 30, 2026
- Valid through
- September 6, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding has a verified Strong Buy consensus. The same dataset has an average price target of $42.40.
How far are Tonix Pharmaceuticals Holding's low and high targets from the recorded price?
The low target implies +61.9%, while the high target implies +378.3%.
How many analysts are included in Tonix Pharmaceuticals Holding's consensus?
The verified consensus includes 5 analysts.
How is Tonix Pharmaceuticals Holding's target upside or downside calculated?
The average target of $42.40 is divided by the recorded price of $13.59, then one is subtracted to produce +212%. This does not guarantee a future return.
When was Tonix Pharmaceuticals Holding's analyst forecast verified?
The data was verified on 2026-08-30. The dataset is valid through 2026-09-06.